[Protective effects of administration of enalapril maleate on rat myocardial damage in early stage of burns]. 2007

Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma, Burns and Combined Injury, the Third Military Medical University, Chonqing, PR China.

OBJECTIVE To investigate the preventive and therapeutic effects of enalapril maleate (Enalaprilat) (E) on myocardial damage in early stage after burns. METHODS A total of 60 SD rats were subjected to 30% TBSA III degree scald injury, and randomly divided into scald group (with conventional fluid transfusion after scald) and ENA group (with intraperitoneal injection of 1 mg/kg Enalaprilat after scald). Normal control consisted of 6 rats. Plasma levels of cTnI and CK-MB were determined in all the groups at 1, 3, 6, 12, 24 post-scald hours (PSH) by enzyme linked immunosorbent assay. The pathological changes in myocardium were observed at the same time-points. RESULTS (1) The serum level of cTnI and CK-MB in scald group were significantly higher than that of normal controls at each time-point (P < 0.01). The serum level of cTnI and CK-MB in ENA group were (1.32 +/- 0.12 microg/L to 2.47 +/- 0.22 microg/L) and (438 +/- 68 U/L to 5569 +/- 322 U/L), respectively, which were obviously lower than those in B group (6.42 +/- 0.96 microg/L to 15.10 +/- 3.69 microg/L) and (2556 +/- 74 U/L to 8047 +/- 574 U/L, P < 0.05 or P < 0.01) at different time-points. (2) Compared with normal controls, cloudy swelling, stromal blood vessel dilatation and congestion inflammatory cell infiltration were observed in scald group, but these pathological changes were less marked in ENA group. CONCLUSIONS Severe myocardial damage in rat occurred early after burns. Enalaprilat injection can markedly alleviate myocardial damage.

UI MeSH Term Description Entries
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D052279 Creatine Kinase, MB Form An isoenzyme of creatine kinase found in the CARDIAC MUSCLE. Isoenzyme CPK-MB,MB Creatine Kinase,Myocardial Creatine Kinase,CPK-MB, Isoenzyme,Creatine Kinase, MB,Creatine Kinase, Myocardial,Isoenzyme CPK MB,Kinase, MB Creatine,Kinase, Myocardial Creatine
D019210 Troponin I A TROPONIN complex subunit that inhibits ACTOMYOSIN ATPASE activity thereby disrupting ACTIN and MYOSIN interaction. There are three troponin I subtypes: troponin I1, I2 and I3. Troponin I3 is cardiac-specific whereas troponin I1 and I2 are skeletal subtypes. Troponin I3 is a BIOMARKER for damaged or injured CARDIAC MYOCYTES and mutations in troponin I3 gene are associated with FAMILIAL HYPERTROPHIC CARDIOMYOPATHY. Troponin I1,Troponin I2,Troponin I3,Troponin-I
D032383 Myocytes, Cardiac Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC). Cardiomyocytes,Muscle Cells, Cardiac,Muscle Cells, Heart,Cardiac Muscle Cell,Cardiac Muscle Cells,Cardiac Myocyte,Cardiac Myocytes,Cardiomyocyte,Cell, Cardiac Muscle,Cell, Heart Muscle,Cells, Cardiac Muscle,Cells, Heart Muscle,Heart Muscle Cell,Heart Muscle Cells,Muscle Cell, Cardiac,Muscle Cell, Heart,Myocyte, Cardiac

Related Publications

Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
September 1987, Journal of molecular and cellular cardiology,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
February 1985, The Tohoku journal of experimental medicine,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
May 1978, Archives of surgery (Chicago, Ill. : 1960),
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
January 1985, Psychopharmacology,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
July 1996, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
March 2002, Burns : journal of the International Society for Burn Injuries,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
January 1993, Clinical therapeutics,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
January 2006, Cell biochemistry and function,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
January 2018, BioMed research international,
Bing-qian Zhang, and Yue-sheng Huang, and Jia-ping Zhang, and Dong-xia Zhang, and Yong-ming Dang, and Guang Wang, and Jiong-yu Hu, and Ze-yuan Lei, and Rong Xiao
May 1991, European journal of pharmacology,
Copied contents to your clipboard!